TrialsgrambetaRCTs are beautiful

NELSON

2020

Dutch-Belgian Lung Cancer Screening Trial

In 15,789 high-risk men (and a small subgroup of women), volume-based LDCT at baseline, 1, 3 and 5.5 years reduced lung-cancer mortality at 10 years compared with no screening.

Result

Efficacy: Lung-cancer mortality at 10 yearsRR 0.76 (95% CI 0.61-0.94)

Below 1 favours volume-based LDCT at baseline, 1, 3 and 5.5 years, above 1 favours no screening.

Also reported: Women RR 0.67 (95% CI 0.38–1.14).

Original publication
Subtopic
Low-dose CT
Design
Multicentre RCT, Netherlands/Belgium
Relevance
Important: one of several pillars.
Source
de Koning HJ, et al. N Engl J Med. 2020;382(6):503-513.doi 10.1056/NEJMoa1911793

Discussion & critique

Confirmed NLST in a European population versus no-screening; volume-based criteria reduced false positives.

Discussed in podcasts